Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

R136S, or the “Christchurch mutation,” appears to protect against Alzheimer’s disease by suppressing inflammatory signaling ...

A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...

A study reveals that the APOE3-R136S mutation delays Alzheimer’s disease by inhibiting the cGAS-STING immune pathway. This ...

A rare gene mutation that delays Alzheimer's disease does so by damping inflammatory signaling in brain-resident immune cells, according to a preclinical study led by investigators at Weill ...

Three Siblings, One Fatal Gene: A Family’s Fight Against Early-Onset Alzheimer’s Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms ...

A groundbreaking study has revealed that a rare gene variant, APOE3-R136S, delays the onset of Alzheimer's disease by ...

In 2023, neurologists at a memory clinic in China diagnosed a 19-year-old with what they believed to be Alzheimer's disease – ...

Dec. 1, 2021 — A gene mutation linked to Alzheimer's disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study.